Johnson & Johnson’s $1.75 Billion Acquisition of Alios BioPharma

Johnson & Johnson announced a definitive agreement to acquire Alios BioPharma, a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash. Cravath represented Johnson & Johnson in the transaction. The closing is subject to clearance under the Hart‑Scott‑Rodino Antitrust Improvements Act and other customary closing conditions. The transaction is expected to close during the fourth quarter of 2014. More >>

Tags:  New York

Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility

Cooley LLP announced today that it advised Horizon Pharma, Inc. on the completion of its acquisition of Vidara Therapeutics International plc. In connection with the acquisition, Horizon and Vidara have combined to form parent company Horizon Pharma plc, which is incorporated in Ireland. Concurrently with the acquisition, Horizon entered into a five-year $300 million term loan facility and related uncommitted facilities. More >>

Tags:  San Diego

Einstein Noah Restaurant Group to be Acquired by JAB Holding Company

Alston & Bird client Einstein Noah Restaurant Group has entered into a definitive agreement to be acquired by JAB Holding Company, a German conglomerate, for about $374 million.

Based in Lakewood, CO, Einstein Noah operates, franchises and licenses more than 855 restaurants in 42 states and Washington, D.C. Its bagel shops include Einstein Brothers Bagels, Noah’s New York Bagels and Manhattan Bagel. More >>

Tags:  Atlanta | Charlotte | Washington

Simpson Thacher Represents Initial Purchasers in $5.75 Billion Notes Offering by Roche

The Firm recently represented Deutsche Bank, J.P. Morgan, MUFG and Credit Suisse as bookrunners for a $5.75 billion offering by Roche Holdings, Inc. of notes, guaranteed by Roche Holding Ltd. The offering consisted of six series of notes, including three-year and five-year floating rate notes and three-year, five-year, seven-year, and ten-year fixed rate notes. The offering was conducted in reliance upon Rule 144A and Regulation S under the Securities Act of 1933. The proceeds of the offering were used for general corporate purposes, including the funding of Roche’s tender offer for the shares of Intermune, Inc. More >>

Tags:  Simpson Thacher & Bartlett LLP | London

Kirkland Advises Vista Equity Partners in its Acquisition of TIBCO Software Inc.

Kirkland & Ellis LLP represents Vista Equity Partners, a leading private equity firm focused on software, data and technology-enabled businesses, which today announced it entered into a definitive agreement to acquire TIBCO Software Inc. (NASDAQ: TIBX), a global leader in infrastructure and business intelligence software. Under the terms of the agreement, TIBCO stockholders will receive $24.00 per share in cash, or a total of approximately $4.3 billion, including the assumption of net debt. The transaction, which is expected to close in the fourth calendar quarter of 2014, is subject to approval by TIBCO stockholders, regulatory approvals and other customary closing conditions. More >>

Tags:  Kirkland & Ellis LLP | New York | San Francisco

Mayer Brown advises on €1.35 billion refinancing of Budapest Airport

Leading global law firm Mayer Brown has advised Budapest Airport on the refinancing of €1.35 billion loan facilities and associated interest rate swaps.The refinancing includes a €1 billion five-year senior term loan and a €300 million junior facility.

Budapest Airport was acquired in 2007 by a consortium of investors including AviAlliance (formerly Hochtief Airport), Caisse de Depot et Placement du Quebec, the Government of Singapore’s investment arm Malton and KFW Ipex Bank. More >>

Tags:  Mayer Brown LLP | London

DLA Piper represents Pacific DataVision in equity raise and acquisition of spectrum licenses

DLA represented Pacific DataVision, Inc., a provider of mobile workforce management solutions, in a 144A offering of shares of its common stock worth US$218 million. The firm also represented Pacific DataVision in its US$100 million acquisition of FCC spectrum licenses from Sprint Corporation, as well as its licensing transaction of US$17.5 million by Motorola Solutions, Inc. More >>

Tags:  DLA Piper | Chicago | New York | San Diego

Gordon & Rees Opens Tampa Office and Continues National Expansion

Gordon & Rees opened its newest office in Tampa to serve clients’ needs in Northern and Central Florida. The Tampa office will complement the firm’s already existing Miami office to offer the highest quality legal services at affordable rates throughout the state of Florida. Tampa is the firm’s 32nd U.S. location since Gordon & Rees was founded nearly 40 years ago. More >>

Tags:  Gordon Rees Scully Mansukhani, LLP | Tampa

Hogan Lovells Advises TESARO on Closing of US$201.25 Million Public Offering

Hogan Lovells represented TESARO, Inc. (Nasdaq: TSRO), an oncology-focused biopharmaceutical company, in its closing of a US$201.25 million public offering of three percent convertible senior notes due in 2021, including full exercise of the underwriters’ option.

TESARO used approximately US$20.83 million of the net proceeds from the offering to fund the payment of the cost of capped call transactions, and expects to use the remaining net proceeds to fund commercialization activities for rolapitant (oral formulation), clinical trials for rolapitant (intravenous formulation), niraparib and TESARO’s other product candidates, to carry out TESARO’s immuno-oncology platform strategy, and for working capital and general corporate purposes. Citigroup and Deutsche Bank Securities acted as joint book-running managers for the offering, with Leerink Partners, Baird and BMO Capital Markets acting as co-managers. More >>

Tags:  Hogan Lovells | Washington